SBH Sciences provides comprehensive biomarker assay services across multiple platforms that enable us to seamlessly execute complex, high-impact projects that drive scientific advancements. We specialize in ELISA development for the R&D market, multiplex analysis, and automated Western blot technology. SBH supports projects from the initial planning stages to finalizing the study. This includes selecting the biomarker targets and instrumentation to support the project, writing SOPs for all of the work for the project, performing qualifications or validations and optimizing testing conditions, preparing and testing the samples, customizing the analysis, sending data transfers, and providing study reports. SBH optimizes project workflows, provides scientific guidance, and delivers results.
In 2024, our scientists provided biomarker analysis and diagnostic support to over 40 companies. SBH Sciences have developed numerous ELISA kits that are commercially available across global vendors. Additionally, SBH Sciences has tested over 300 biomarkers across various multiplex platforms. Our many state-of-the-art platforms allow SBH Sciences to provide the highest quality services to our customers
Our scientists take a collaborative approach when working with our clients to help identify the appropriate biomarker for their research needs. From there we help you choose the ideal instrument to help you develop, optimize, and qualify the specific assay.
SBH Sciences adheres to Good Laboratory Practices (GLP) guidelines, maintaining the integrity and security of all data. We have recently become Certified Service Provider on the Ella instrument. SBH prides itself on delivering rapid and precise biomarker analysis. Assays developed at SBH Sciences can be transferred to our sister company, SBH Diagnostics, a CLIA certified Contract Research Organization. This allows SBH Sciences to support preclinical projects and continue with them when it becomes clinical samples.
